NASDAQ · Medical - Devices

BRKR (BRKR) Stock

$62.91 +4.76% NASDAQ: BRKR Healthcare

Valuation

MetricValue
Price$62.91
Market Cap$9.58B
P/E Ratio23.24
P/B Ratio3.52
P/S Ratio2.49
EPS (TTM)$-0.15
52-Week High$64.54
52-Week Low$28.53
Dividend Yield0.35%

Financials & Margins

MetricValue
ROE-0.43%
ROA2.70%
ROCE9.40%
Gross Margin45.56%
Operating Margin5.89%
Net Margin-0.34%
Debt/Equity0.68
Current Ratio1.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.4B$2.5B$3.0B$3.4B$3.4B
Operating Profit$413.0M$433.0M$437.0M$253.0M$236.0M
Net Profit$277.0M$297.0M$427.0M$113.0M$-9.0M
EPS$1.81$1.99$2.90$0.76$-0.15
Op Margin17.1%17.1%14.7%7.5%6.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.6B$3.6B$4.3B$5.8B$6.2B
Total Liabilities$2.6B$2.5B$2.8B$4.0B$3.7B
Cash$1.1B$646.0M$488.0M$183.0M$299.0M
Borrowings$1.4B$1.3B$1.4B$2.2B$2.0B

Latest News

Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform MT Newswires · Jul 15, 2026 Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood Business Wire · Jul 15, 2026 BRKR: Raising target price to $63.00 Argus Research · Jul 15, 2026 3 Cash-Producing Stocks We’re Skeptical Of StockStory · Jul 14, 2026 BofA Securities Adjusts Bruker Price Target to $70 From $65 MT Newswires · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$282.0M$274.0M$350.0M$251.0M$134.0M
Investing Cash Flow$-284.0M$-381.0M$-433.0M$-1.9B$-317.0M
Financing Cash Flow$-154.0M$-278.0M$-152.0M$-19.0M$-20.0M
Net Cash Flow$386.0M$-423.0M$-157.0M$-305.0M$116.0M
Free Cash Flow$190.0M$145.0M$243.0M$136.0M$14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.52
EV / EBITDA20.22
FCF Yield0.60%
Quick Ratio0.72
Interest Coverage3.93
Return 1Y70.40%
Return 3Y-18.87%
Return 5Y-24.56%

Ownership

Insiders Held26.96%
Institutions Held92.85%
Institutions Float Held127.12%
Institutional HolderSharesReport Date
Orbis Allan Gray Ltd17,940,0762026-03-31
FMR, LLC16,101,8032026-03-31
Blackrock Inc.11,180,8062026-03-31
Pallas Capital Advisors Llc9,481,8212026-03-31
Vanguard Portfolio Management LLC4,855,9152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BTSGBrightSpring Health Services, Inc. Common Stock $71.98 -1.28% 89.58 $14.13B 0.00%
CHE $534.79 -0.85% 23.91 $7.10B 0.52%
CRSP $46.73 +0.41% -12.98 $4.51B 0.00%
GKOS $166.72 -1.07% -42.65 $9.83B 0.00%
IRTC $112.15 +2.70% 113.40 $3.69B 0.00%

About BRKR

BRKR is led by CEO Frank H. Laukien, employs 11,085 people, headquartered in Billerica, US, publicly traded since 2000.

BRKR stock trades at $62.91 with a market capitalization of $9.58B. The stock is valued at a price-to-earnings (P/E) ratio of 23.24, price-to-book of 3.52, price-to-sales of 2.49. Over the past 52 weeks the stock has ranged between $28.53 and $64.54, and currently trades 2.5% below its 52-week high. It pays a dividend yielding 0.35%.

On profitability, BRKR generates a return on equity (ROE) of -0.43%, return on capital employed of 9.40%, an operating margin of 5.89%, a net profit margin of -0.34%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides